Systematic (IUPAC) name | |
---|---|
N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methyl-2,2-diphenylacetamide | |
Clinical data | |
Pregnancy cat. | ? |
Legal status | ? |
Identifiers | |
CAS number | 153205-46-0 |
ATC code | ? |
PubChem | CID 179340 |
ChemSpider | 156107 |
UNII | D0VK52NV5M |
ChEMBL | CHEMBL1190199 |
Chemical data | |
Formula | C27H30N2O2 |
Mol. mass | 414.539 g/mol |
SMILES | eMolecules & PubChem |
|
|
(verify) |
(what is this?)
Asimadoline (EMD-61753) is a drug which acts as a peripherally selective κ-opioid agonist.[1][2] Because of its poor ability to cross the blood-brain barrier, asimadoline lacks the psychotomimetic effects of centrally acting kappa agonists, and consequently has more potential for medical use, and has been researched as a possible treatment for irritable bowel syndrome, with reasonable efficacy seen in clinical trials.[3][4]
|